Online citations, reference lists, and bibliographies.
← Back to Search

5-year Outcomes Of Transcatheter Aortic Valve Replacement Or Surgical Aortic Valve Replacement For High Surgical Risk Patients With Aortic Stenosis (PARTNER 1): A Randomised Controlled Trial

M. Mack, M. León, C. Smith, D. Miller, Jodi J. Akin
Published 2015 · Medicine
Referenced 1 time by Citationsy Users

Save to my Library
Download PDF
Analyze on Scholarcy
Share
BACKGROUND The Placement of Aortic Transcatheter Valves (PARTNER) trial showed that mortality at 1 year, 2 years, and 3 years is much the same with transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) for high-risk patients with aortic stenosis. We report here the 5-year outcomes. METHODS We did this randomised controlled trial at 25 hospitals, in Canada (two), Germany (one), and the USA (23). We used a computer-generated randomisation sequence to randomly assign high-risk patients with severe aortic stenosis to either SAVR or TAVR with a balloon-expandable bovine pericardial tissue valve by either a transfemoral or transapical approach. Patients and their treating physicians were not masked to treatment allocation. The primary outcome of the trial was all-cause mortality in the intention-to-treat population at 1 year, we present here predefined outcomes at 5 years. The study is registered with ClinicalTrials.gov, number NCT00530894. FINDINGS We screened 3105 patients, of whom 699 were enrolled (348 assigned to TAVR, 351 assigned to SAVR). Overall mean Society of Thoracic Surgeons Predicted Risk of Mortality score was 11·7%. At 5 years, risk of death was 67·8% in the TAVR group compared with 62·4% in the SAVR group (hazard ratio 1·04, 95% CI 0·86-1·24; p=0·76). We recorded no structural valve deterioration requiring surgical valve replacement in either group. Moderate or severe aortic regurgitation occurred in 40 (14%) of 280 patients in the TAVR group and two (1%) of 228 in the SAVR group (p<0·0001), and was associated with increased 5-year risk of mortality in the TAVR group (72·4% for moderate or severe aortic regurgitation vs 56·6% for those with mild aortic regurgitation or less; p=0·003). INTERPRETATION Our findings show that TAVR as an alternative to surgery for patients with high surgical risk results in similar clinical outcomes. FUNDING Edwards Lifesciences.
This paper references
10.1016/j.jtcvs.2011.04.026
Transesophageal echocardiographic scoring for transcatheter aortic valve implantation: impact of aortic cusp calcification on postoperative aortic regurgitation.
A. Colli (2011)
10.1016/S0140-6736(15)60290-2
5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial
S. Kapadia (2015)
10.1097/01.SA.0000431219.37059.D1
Two-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement
S. Kodali (2013)
10.1016/j.amjcard.2014.07.019
Comparison of hemodynamic performance of the balloon-expandable SAPIEN 3 versus SAPIEN XT transcatheter valve.
I. Amat-Santos (2014)
10.1161/CIRCULATIONAHA.110.948877
Transcatheter Aortic Valve Implantation: Durability of Clinical and Hemodynamic Outcomes Beyond 3 Years in a Large Patient Cohort
R. Gurvitch (2010)
cation severity with the degree of aortic regurgitation after transcatheter aortic valve implantation
V Babaliaros (2010)
10.1016/S0735-1097(14)61690-9
30 DAY OUTCOMES FROM THE PARTNER II TRIAL FOR TRANSAPICAL AND TRANSFEMORAL 29MM TAVR IN INOPERABLE PATIENTS WITH THE EDWARDS SAPIEN XT
V. Babaliaros (2014)
10.1016/j.jacc.2012.07.003
Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial.
P. Généreux (2012)
10.1016/j.jacc.2013.04.036
The impact of integration of a multidetector computed tomography annulus area sizing algorithm on outcomes of transcatheter aortic valve replacement: a prospective, multicenter, controlled trial.
R. Binder (2013)
10.3109/14017437009134236
Postoperative aortic regurgitation related to peroperative blood flowmetry in ball valve replacement.
G. Semb (1970)
10.1016/j.athoracsur.2013.05.093
Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial.
T. Dewey (2013)
10.1016/j.jcin.2012.09.019
Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve.
R. Binder (2013)
10.1056/NEJMoa1008232
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.
M. León (2010)
10.1001/jama.2013.282043
Outcomes following transcatheter aortic valve replacement in the United States.
M. Mack (2013)
cant paravalvular aortic insuffi ciency in transapical-aortic valve implantation
A Colli (2012)
10.1016/j.jcin.2009.07.003
Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence.
D. Détaint (2009)
10.1016/j.jacc.2011.08.050
Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry.
N. Moat (2011)
10.1161/CIRCULATIONAHA.110.013425
Transapical Aortic Valve Implantation: Analysis of Risk Factors and Learning Experience in 299 Patients
J. Kempfert (2011)
10.1056/NEJMoa1202277
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis.
R. Makkar (2012)
10.1055/S-0031-1297514
Aortic valve calcium scoring (AVCS) is a predictor of significant paravalvular aortic insufficiency in transapical aortic valve implantation
M. Haensig (2012)
10.1016/j.jacc.2011.11.045
Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation.
H. Jilaihawi (2012)
10.1097/01.SA.0000410147.99581.D4
Transcatheter Versus Surgical Aortic-Valve Replacement in High-Risk Patients
C. Smith (2012)
10.1016/j.jacc.2013.01.047
Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature.
G. Athappan (2013)
FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high risk patients
M Gilard (2012)
10.1016/j.athoracsur.2014.07.051
The association of transcatheter aortic valve replacement availability and hospital aortic valve replacement volume and mortality in the United States.
J. Brennan (2014)
10.1136/hrt.2010.217158
Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry
M. Abdelwahab (2011)
10.1093/ejcts/ezr244
Aortic valve calcium scoring is a predictor of significant paravalvular aortic insufficiency in transapical-aortic valve implantation.
M. Haensig (2012)
10.1161/CIRCULATIONAHA.114.009834
Long-Term Outcomes of Inoperable Patients With Aortic Stenosis Randomly Assigned to Transcatheter Aortic Valve Replacement or Standard Therapy
S. Kapadia (2014)
10.1016/j.jcin.2011.09.014
Transcatheter aortic valve implantation: assessing the learning curve.
O. Alli (2012)
10.1016/j.ijcard.2010.03.004
Association of aortic valve calcification severity with the degree of aortic regurgitation after transcatheter aortic valve implantation.
R. Koos (2011)
10.1016/j.echo.2013.01.013
Implementation of echocardiography core laboratory best practices: a case study of the PARTNER I trial.
P. Douglas (2013)
10.1016/j.jtcvs.2012.01.055
Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial.
D. Miller (2012)
10.1016/j.jacc.2012.08.960
Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience.
J. Rodés-Cabau (2012)
10.1056/NEJMoa1114705
Registry of transcatheter aortic-valve implantation in high-risk patients.
M. Gilard (2012)



This paper is referenced by
10.1097/ACO.0000000000000558
The ethics of interventional procedures for patients too ill for surgery
Caroline G Kan (2018)
10.15406/ICPJL.2017.04.00104
Transcatheter aortic valve replacement
F. Vilela (2017)
10.1080/08998280.2018.1482515
Validation of a low-dose contrast 64-slice cardiac computed tomography angiography protocol for aortic valve annulus sizing
E. Holper (2018)
10.1007/s40119-016-0077-z
Late Paravalvular Aortic Regurgitation: Migration of the Valve or Late Recoil?
A. Karimi (2017)
10.1016/j.jtcvs.2017.03.144
Readmission rates after transcatheter aortic valve replacement in high‐ and extreme‐risk patients with severe aortic stenosis
Jessica Forcillo (2017)
10.1016/j.jacc.2018.12.078
Long-Term Risk of Infective Endocarditis After Transcatheter Aortic Valve Replacement.
J. Butt (2019)
10.4070/kcj.2019.0044
Aortic Stenosis and Transcatheter Aortic Valve Implantation: Current Status and Future Directions in Korea
Choongki Kim (2019)
10.1016/j.hlc.2016.01.005
Transcatheter versus Surgical Aortic Valve Replacement in High-risk Patients: A propensity-score matched analysis.
India Zweng (2016)
10.1007/978-3-319-93396-2_2
Relevant Clinical Trials
A. Watkins (2018)
10.1136/bmjopen-2018-022437
Comparative survival and role of STS score in aortic paravalvular leak after SAVR or TAVR: a retrospective study from the USA
Ratnasari Padang (2018)
10.1016/j.iccl.2018.06.002
When to Choose Surgery in the Era of Transcatheter Aortic Valve Replacement.
M. C. Wyler von Ballmoos (2018)
10.21037/acs.2017.09.10
Long term outcomes of transcatheter aortic valve implantation (TAVI): a systematic review of 5-year survival and beyond.
Adam Chakos (2017)
10.1161/CIRCULATIONAHA.117.029479
The Fluid Mechanics of Transcatheter Heart Valve Leaflet Thrombosis in the Neosinus
Prem A. Midha (2017)
10.1016/J.REPCE.2015.11.011
[Comment on "1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement. Results from the Italian OBSERVANT study"].
Lino Patrício (2015)
10.1016/j.athoracsur.2015.05.076
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis: A Considered Opinion.
Gerard J. Fitzmaurice (2015)
10.4414/smw.2016.14299
Transcatheter aortic valve implantation today and tomorrow.
P. Wenaweser (2016)
Minimally invasive cardiac surgery continues to evolve and expand as technology and surgeon experience
Hossein Amirjamshidi (2019)
10.1016/j.jacc.2015.03.558
Expanding the Transcatheter Aortic Valve Replacement Field Under Continued Surveillance: The GARY Registry.
J. Paradis (2015)
10.1532/hsf.2913
Comparison of Short and Mid-Term Mortality and Morbidity in Patients With Severe Aortic Stenosis (Intermediate/High Risk) Who Underwent Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement.
Mehmet Ali Yesiltas (2020)
10.1136/heartjnl-2017-312861
Is bioprosthetic leaflet thrombosis a trigger to valve degeneration?
M. Doris (2018)
10.1016/j.ihj.2017.02.017
Clinical outcome in nonagenarians undergoing transcatheter valve replacement
O. Mendiz (2017)
10.1007/s10554-017-1155-6
Dynamic changes in aortic impedance after transcatheter aortic valve replacement and its impact on exploratory outcome
Y. Kobayashi (2017)
10.1111/jocs.14309
Aortic valve replacement with pulmonary hypertension: Meta‐analysis of 70 676 patients
R. Rocha (2019)
10.1016/j.amjcard.2016.04.019
Feasibility and Safety of Transcatheter Aortic Valve Implantation Performed Without Intensive Care Unit Admission.
F. Leclercq (2016)
10.5606/tgkdc.dergisi.2019.17174
Comparison of patient-prothesis mismatch after surgical aortic valve replacement and transcatheter aortic valve implantation.
Bilge Ecemiş Yılmaz (2019)
10.1253/circj.CJ-19-0101
Midterm Outcomes of Transcatheter Aortic Valve Replacement in Dialysis Patients With Aortic Valve Stenosis.
K. Maeda (2019)
10.1016/S0140-6736(15)60568-2
PARTNERs in the future of surgical aortic valve replacement
A. Kappetein (2015)
10.1016/j.jcin.2020.01.238
Frailty and Bleeding in Older Adults Undergoing TAVR or SAVR: Insights From the FRAILTY-AVR Study.
Melissa Bendayan (2020)
10.1016/j.cjca.2019.12.022
Clinical Impact of Preprocedural Moderate or Severe Mitral Regurgitation on Outcomes After Transcatheter Aortic Valve Replacement.
Mizuki Miura (2019)
10.1007/s00392-019-01509-8
Transvascular transcatheter aortic valve implantation in 2017
L. Gaede (2019)
10.1016/j.amjcard.2019.11.002
Comparison of Survival of Transfemoral Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Aortic Stenosis in Low-Risk Patients Without Coronary Artery Disease.
M. Virtanen (2019)
10.1016/j.jtcvs.2020.01.084
Subclinical valve thrombosis in transcatheter aortic valve implantation: A systematic review and meta-analysis.
Kei Woldendorp (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar